Your browser doesn't support javascript.
loading
Survival outcomes and prognostic factors for first-line abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer.
Tseng, Chi-Shin; Yang, Jui-Han; Huang, Shi-Wei; Wang, Yu-Jen; Chen, Chung-Hsin; Pu, Yeong-Shiau; Cheng, Jason Chia-Hsien; Huang, Chao-Yuan.
Affiliation
  • Tseng CS; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, No.1, Jen Ai road, Section 1, Taipei, Taiwan.
  • Yang JH; Department of Urology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
  • Huang SW; Department of Education, National Taiwan University Hospital, Taipei, Taiwan.
  • Wang YJ; Department of Urology, National Taiwan University Hospital Yun-Lin Branch, Taipei, Taiwan.
  • Chen CH; Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Pu YS; Department of Radiation Oncology, School of Medicine, Fu-Jen Catholic University Hospital and College of Medicine, New Taipei City, Taiwan.
  • Cheng JC; Department of Urology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
  • Huang CY; Department of Urology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
BMC Cancer ; 23(1): 568, 2023 Jun 20.
Article in En | MEDLINE | ID: mdl-37340337
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Taiwan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Taiwan